机构地区:[1]厦门大学附属成功医院干部病房,福建厦门361000
出 处:《中国当代医药》2022年第16期83-86,90,共5页China Modern Medicine
基 金:福建省卫生计生科研人才培养项目(2018-2-88)。
摘 要:目的探讨普罗布考联合冠心病二级预防对老年陈旧性心肌梗死患者氧化应激指标及心功能的影响。方法选取2019年10月至2021年1月厦门大学附属成功医院收治的86例老年性陈旧性心肌梗死患者作为研究对象,按照随机数字表法分为观察组(43例)与对照组(43例)。对照组采用冠心病二级预防方案,观察组在对照组的基础上给予普罗布考治疗。比较两组患者的氧化应激指标[超氧化物歧化酶(SOD)、丙二醛(MDA)、谷胱甘肽过氧化物酶(GSH-Px)],超声心动图指标[左心室射血分数(LVEF)、心排血量(CO)、心排血指数(CI)及平均肺动脉压]、心功能分级及治疗期间的不良反应发生情况。结果两组患者治疗后的SOD、GSH-Px水平高于治疗前,且观察组治疗后的SOD、GSH-Px水平高于对照组,差异有统计学意义(P<0.05);两组患者治疗后的MDA水平低于治疗前,且观察组治疗后的MDA水平低于对照组,差异有统计学意义(P<0.05)。两组患者治疗后的LVEF、CO、CI水平高于治疗前,且观察组治疗后的LVEF、CO、CI高于对照组,差异有统计学意义(P<0.05);两组患者治疗后的平均肺动脉压低于治疗前,且观察组治疗后的平均肺动脉压低于对照组,差异有统计学意义(P<0.05)。两组患者治疗后的心功能分级优于治疗前,且观察组治疗后的心功能分级情况优于对照组,差异有统计学意义(P<0.05)。两组患者治疗期间的不良反应总发生率比较,差异无统计学意义(P>0.05)。结论普罗布考联合冠心病二级预防能显著降低老年陈旧性心肌梗死患者的氧化应激水平,改善心功能及患者预后,安全性较好。Objective To investigate the influence of Probucol combined with secondary prevention of coronary heart disease on oxidative stress indexes and cardiac function in elderly patients with old myocardial infarction.Methods A total of 86 elderly patients with old myocardial infarction treated in Chenggong Hospital Affiliated to Xiamen University from October 2019 to January 2021 were selected as the research objects.According to random number table method,they were divided into the observation group(43 cases)and the control group(43 cases).The control group was treated with secondary prevention of coronary heart disease,and the observation group was treated with Probucol on the basis of the control group.The oxidative stress indexes(superoxide dismutase[SOD],malondialdehyde[MDA],glutathione peroxidase[GSH-Px]),echocardiographic indexes(left ventricular ejection fraction[LVEF],cardiac output[CO],cardiac output index[CI]and the mean pulmonary artery pressure),cardiac function grade,adverse reactions during treatment were compared between the two groups.Results The levels of SOD and GSH-Px in the two groups after treatment were higher than those before treatment,and the levels of SOD and GSH-Px in the observation group after treatment were higher than those in the control group,the differences were statistically significant(P<0.05).The MDA levels of the two groups after treatment were lower than those before treatment,and the MDA level of the observation group after treatment was lower than that of the control group,the differences were statistically significant(P<0.05).The levels of LVEF,CO and CI in the two groups after treatment were higher than those before treatment,and the levels of LVEF,CO and CI in the observation group after treatment were higher than those in the control group,the differences were statistically significant(P<0.05).The levels of mean pulmonary artery pressure of the two groups after treatment were lower than those before treatment,and the mean pulmonary artery pressure of the observation group
分 类 号:R542.22[医药卫生—心血管疾病]
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...